Leishmania donovani BPK282A1 complete genome, chromosome 7.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799594.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
ubiquitin activating E1 enzyme, putative
ATP-dependent DEAD/H RNA helicase, putative
acyl-CoA dehydrogenase, mitochondrial precursor, putative
cytochrome c1, heme protein, mitochondrial precursor, putative
cobalamin-dependent methionine synthase, putative
protein phosphatase 2A, regulatory subunit B, putative
phosphatidylglycerophosphate synthase-like protein
acetylornithine deacetylase-like protein
electron transfer flavoprotein-ubiquinone oxidoreductase, putative
topoisomerase-related function protein-like protein
phosphoacetylglucosamine mutase-like protein
ubiquitin-conjugating enzyme e2, putative
peptidyl-prolyl cis-trans isomerase/rotamase, putative
proteasome regulatory non-ATP-ase subunit, putative
peptide methionine sulfoxide reductase-like